Intercritical Gout Clinical Trial
The purpose of this study is to determine if once-daily treatment with colchicine, compared to placebo, is effective in preventing gout flares in patients who are initiating therapy with allopurinol.
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05522504 -
Distribution of Immune Cells and Their Subtypes in Peripheral Blood of Gout
|
||
Completed |
NCT00829829 -
PREventative Study Against URate-lowering Drug-induced Gout Exacerbations 1
|
Phase 3 |